Almost 100 Million Doses of Johnson & Johnson COVID-19 Vaccine to be Donated to Lower Income Countries Through COVAX

Johnson & Johnson (the Company) welcomes the decision of EU Member States along with Norway and Iceland (Team Europe) to donate almost 100 million doses of its COVID-19 vaccine through the COVAX Facility. As a practical rapid response to the urgent need to scale up equitable access to vaccines, these doses will be utilized to help protect individuals in lower-income countries. Supported by the European Commission, Team Europe are providing these doses under an agreement signed recently by the Government of Belgium (acting on behalf of Team Europe), Gavi, The Vaccine Alliance (GAVI) and Johnson & Johnson. The agreement will enable doses of the Company’s vaccine to be shipped directly to COVAX for the benefit of low- and middle-income countries through the remainder of this year and into early 2022.“We welcome the leadership shown by the European Commission and Team Europe in transferring these doses to accelerate COVID-19 vaccination in lower income countries and to help address the global vaccine equity challenge,” said Paul Stoffels, M.D., Vice Chairman of the Executive Committee and Chief Scientific Officer. “We will continue to support governments that have doses of our vaccine to share, particularly through the COVAX Facility as we believe that it is an essential mechanism to help combat the pandemic globally.”At a time when only 4.7 percent[1] of people in low-income countries have received at least one dose of a COVID-19 vaccine, a global effort is nee...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Our Company Source Type: news